|
TTC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.140980E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.067630E-02 |
| Normal-vs-Stage2 |
2.044200E-04 |
| Normal-vs-Stage3 |
1.144970E-03 |
| Normal-vs-Stage4 |
3.600000E-02 |
| Stage1-vs-Stage2 |
1.805640E-02 |
| Stage1-vs-Stage3 |
1.603960E-01 |
| Stage1-vs-Stage4 |
9.826000E-01 |
| Stage2-vs-Stage3 |
2.344200E-01 |
| Stage2-vs-Stage4 |
5.149700E-02 |
| Stage3-vs-Stage4 |
2.947400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.647100E-04 |
| Normal-vs-AfricanAmerican |
2.998400E-03 |
| Normal-vs-Asian |
2.591000E-01 |
| Caucasian-vs-AfricanAmerican |
3.039400E-01 |
| Caucasian-vs-Asian |
1.740030E-02 |
| AfricanAmerican-vs-Asian |
1.904160E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.013620E-04 |
| Normal-vs-Female |
1.005820E-01 |
| Male-vs-Female |
9.211700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.021800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.041000E-04 |
| Normal-vs-Age(61-80Yrs) |
7.602100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.294400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.732600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.582400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.838200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.500200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.191000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.497600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.670800E-01 |
| Normal-vs-Grade 2 |
3.664500E-02 |
| Normal-vs-Grade 3 |
1.246270E-04 |
| Normal-vs-Grade 4 |
9.456300E-03 |
| Grade 1-vs-Grade 2 |
5.643000E-01 |
| Grade 1-vs-Grade 3 |
1.365400E-01 |
| Grade 1-vs-Grade 4 |
2.802800E-01 |
| Grade 2-vs-Grade 3 |
4.976000E-03 |
| Grade 2-vs-Grade 4 |
2.357600E-01 |
| Grade 3-vs-Grade 4 |
3.871800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.437600E-01 |
| Normal-vs-ccB subtype |
1.61850000000019E-05 |
| ccA subtype-vs-ccB subtype |
2.34850000002673E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.197600E-03 |
| Normal-vs-N1 |
7.923200E-01 |
| N0-vs-N1 |
2.090800E-01 |
|
|
